Cite
HARVARD Citation
Morand, E. et al. (2023). Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus. Annals of the rheumatic diseases. 82 (5), pp. 639-645. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Morand, E. et al. (2023). Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus. Annals of the rheumatic diseases. 82 (5), pp. 639-645. [Online].